NFKB1 and colorectal carcinoma: Here, we provide new evidence directly showing that LCN2 prevents CRC cells from undergoing EMT and metastasis/invasion by targeting the promoter activity of NF-κB, which inhibits the NF-κB/snail signaling pathway.